Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of PDR1

Establishing an effective empirical antifungal therapy requires that national surveillance studies be conducted. Herein, we report the clinical outcome of infections with and the microbiological features of Iranian isolates of Candida glabrata derived from patients suffering from candidemia. C. glab...

Descripción completa

Detalles Bibliográficos
Autores principales: Arastehfar, Amir, Daneshnia, Farnaz, Zomorodian, Kamiar, Najafzadeh, Mohammad Javad, Khodavaisy, Sadegh, Zarrinfar, Hossein, Hagen, Ferry, Zare Shahrabadi, Zahra, Lackner, Michaela, Mirhendi, Hossein, Salehi, Mohammadreza, Roudbary, Maryam, Pan, Weihua, Kostrzewa, Markus, Boekhout, Teun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Mechanisms of Resistance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591624/
https://www.ncbi.nlm.nih.gov/pubmed/30936110
http://dx.doi.org/10.1128/AAC.02503-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591624/
https://www.ncbi.nlm.nih.gov/pubmed/30936110
http://dx.doi.org/10.1128/AAC.02503-18

Ejemplares similares